FGF23 neutralization improves bone quality and osseointegration of titanium implants in chronic kidney disease mice. - Wikidata - awgldk - TriplyDB

FGF23 neutralization improves bone quality and osseointegration of titanium implants in chronic kidney disease mice.

FGF23 neutralization improves bone quality and osseointegration of titanium implants in chronic kidney disease mice.

http://www.wikidata.org/entity/Q35065731

about

Roles of the kidney in the formation, remodeling and repair of bone Inhibitor of ppGalNAc-T3-mediated O-glycosylation blocks cancer cell invasiveness and lowers FGF23 levels.The production of fibroblast growth factor 23 is controlled by TGF-β2.Dental implant treatment for renal failure patients on dialysis: a clinical guideline.Relationships between Bone Turnover and Energy Metabolism.FGF23 Neutralizing Antibody Ameliorates Hypophosphatemia and Impaired FGF Receptor Signaling in Kidneys of HMWFGF2 Transgenic Mice.Klotho/FGF23 Axis in Chronic Kidney Disease and Cardiovascular Disease.

P2860

Q26768186-5C2EF697-EDC3-42C2-8F8E-0900E34E7F59 Q33611054-495CFEF2-1258-47D5-8CD4-9371E44A257B Q33890223-7568A6E5-4713-4E49-89C0-93F91B12D319 Q39394204-7E56F1AB-8FDD-43C2-A82E-51B60648DA60 Q39427409-68A44D82-C065-47F4-8D38-D738969506CC Q51701483-52E5E7A3-66D2-42FC-A683-09C63085DED4 Q55442487-C25F5C2F-97C1-45D7-BCB8-0DD3E90745F0

P2860

FGF23 neutralization improves bone quality and osseointegration of titanium implants in chronic kidney disease mice.

http://www.wikidata.org/entity/Q35065731

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

FGF23 neutralization improves ...... n chronic kidney disease mice.

@ast

FGF23 neutralization improves ...... n chronic kidney disease mice.

@en

type

label

FGF23 neutralization improves ...... n chronic kidney disease mice.

@ast

FGF23 neutralization improves ...... n chronic kidney disease mice.

@en

prefLabel

FGF23 neutralization improves ...... n chronic kidney disease mice.

@ast

FGF23 neutralization improves ...... n chronic kidney disease mice.

@en

P1433

Q35065731-10EB9BDA-4903-41EC-8544-EA5B42CFE8D1

P1476

Q35065731-9FC00A72-D1F7-4BFE-B868-C5753E480001

P2093

Q35065731-84865AB8-FAD9-4E0E-A793-C2714FA2D3CA

Q35065731-92799291-0A6B-47A3-9AF0-25B3C7AD964F

Q35065731-9AE6115C-9381-482C-B774-99A31F15D693

Q35065731-9D1C2F31-B3CA-44F9-BE29-6FFCA22AA2CE

Q35065731-9D39A3F8-BBA5-40D7-B18D-54DAAF290826

Q35065731-A47A3D3B-E331-41C1-B47C-C999C40EFC91

Q35065731-A7BFED82-8693-44E9-BD52-089D94C36FB8

Q35065731-B6A597AB-1CDA-4B55-9799-06C61526F666

Q35065731-DEFF9946-4170-45BE-A4A3-B926E516AAA8

P2860

Q35065731-05BCE85B-E12C-47B5-B7D6-2E053B8624C9

Q35065731-0D5C0E92-C6F0-4C95-B818-9B838D1343BA

Q35065731-0FE157B4-7145-4F91-95B6-C0EB213C56C2

Q35065731-13B6645D-1834-4A51-90C4-E8A90D2F7D1B

Q35065731-181E4E75-995E-46C0-884D-4108AEE23958

Q35065731-1FA8CF5F-8001-4B97-A033-55D19439255C

Q35065731-23B8B101-0F23-4B05-9D16-8E11146E7667

Q35065731-25D31683-C203-48B3-8A7D-89F776BE7A77

Q35065731-27ACE7A5-859A-4C6A-BDD2-9B532568A652

Q35065731-327BDD83-21B3-4DB8-AFC2-DB79EB24507D

P2888

Q35065731-7D8F4AE8-ADCF-42E3-A1A9-DD7BA6C6B92A

P304

Q35065731-0FEED888-8B00-4BED-8DAB-AF67EE513095

P31

Q35065731-1B8516B8-FB74-4FD3-8D0C-3449534D2284

P356

Q35065731-ABF36BEE-46F8-43EE-9A38-D5F382A05ECA

P407

Q35065731-B4434E67-10FE-4663-AAB3-05816E984DA3

P478

Q35065731-2C22BB8B-A18B-4EDC-B240-9FAD49346557

P577

Q35065731-8EE0D527-5968-4465-A2DC-78265BDD6CAD

P5875

Q35065731-0C85C408-182E-4B6A-BFBB-C52258DF0D1B

P698

Q35065731-9B66906F-6A2C-4A89-A513-ED49D4F04A0C

P932

Q35065731-8A04006B-613C-4367-A445-07EE75EE2E73

P356

P1433

Scientific Reports

P1476

FGF23 neutralization improves ...... n chronic kidney disease mice.

@en

P2093

Beate Lanske

http://www.w3.org/2001/XMLSchema#string

Ling Ye

http://www.w3.org/2001/XMLSchema#string

Michael Densmore

http://www.w3.org/2001/XMLSchema#string

Ningyuan Sun

http://www.w3.org/2001/XMLSchema#string

Quan Yuan

http://www.w3.org/2001/XMLSchema#string

Reinhold G Erben

http://www.w3.org/2001/XMLSchema#string

Victoria Shalhoub

http://www.w3.org/2001/XMLSchema#string

Weiqing Liu

http://www.w3.org/2001/XMLSchema#string

Yuchen Guo

http://www.w3.org/2001/XMLSchema#string

P2860

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro

FGF23 and Phosphate Wasting Disorders

FGF23 and mineral metabolism, implications in CKD-MBD

Vitamin D deficiency

Prevalence of chronic kidney disease in the United States

Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications.

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.

Bone mass and microarchitecture in CKD patients with fracture

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.

P2888

P304

8304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP08304

http://www.w3.org/2001/XMLSchema#string

P407

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272193505

http://www.w3.org/2001/XMLSchema#string

P698

25665715

http://www.w3.org/2001/XMLSchema#string

P932

4322353

http://www.w3.org/2001/XMLSchema#string